In early 2023, the FDA approved a second treatment for individuals with Alzheimer disease. Do you believe this approval is a serious breakthrough in the treatment of Alzheimer disease? Voice your opinion...
In early 2023, the FDA approved a second treatment for individuals with Alzheimer disease. Do you believe this approval is a serious breakthrough in the treatment of Alzheimer disease? Voice your opinion...
In early 2023, the FDA approved a second treatment for individuals with Alzheimer disease. Do you believe this approval is a serious breakthrough in the treatment of Alzheimer disease? Voice your opinion...
Many patients with Alzheimer disease may become confused, anxious, aggressive, agitated, or restless consistently in the late afternoon or early evening. Do you know when this symptom, known as sundowning,...
Hutchinson-Gilford progeria syndrome affects 1 in 4 million live births. Do you know when the rare genetic syndrome was first described? Find out by answering this question.
As the number of Americans with Alzheimer disease rises, researchers continue to look for reliable biomarkers for the disease. Do you think researchers will find one? Let us know by taking our poll.
Do you think the neurodegeneration that serves as the basis of the biomarker-based concept of suspected non-amyloid pathology can be considered a pre-clinical state of Alzheimer disease? Let us know by...
